|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.65 INR | +1.07% |
|
+1.75% | +40.37% |
| Market Cap | 18.52B 194M 169M 157M 144M 272M 276M 1.85B 726M 9.22B 729M 713M 30.92B | P/E 2024 |
22.4x | P/E 2025 | 21.8x |
|---|---|---|---|---|---|
| Enterprise Value | 18.52B 194M 169M 157M 144M 272M 276M 1.85B 726M 9.22B 729M 713M 30.92B | EV / Sales 2024 |
1.27x | EV / Sales 2025 | 1.45x |
| Free-Float |
56.3% | Yield 2024 * |
-
| Yield 2025 | 0.42% |
| 1 day | +1.07% | ||
| 1 week | +1.75% | ||
| Current month | +1.07% | ||
| 1 month | -2.40% | ||
| 3 months | +37.26% | ||
| 6 months | +53.53% | ||
| Current year | +40.37% |
| 1 week | 55 |  | 58.9 |
| 1 month | 51.38 | | 64.58 |
| Current year | 33.05 | | 64.58 |
| 1 year | 33.05 | | 64.58 |
| 3 years | 30.3 | | 100.9 |
| 5 years | 23.6 | | 100.9 |
| 10 years | 7.2 | | 100.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sanjay Suri
CEO | Chief Executive Officer | 58 | 2026-06-30 |
Sushil Suri
CEO | Chief Executive Officer | 62 | 1992-01-31 |
| Director of Finance/CFO | 59 | 2002-04-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CHM | Chairman | 62 | 1992-01-31 |
| Director/Board Member | 58 | 2019-08-12 | |
Savita
BRD | Director/Board Member | - | 2020-06-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.07% | +1.75% | - | - | 327M | |
| -0.53% | -3.95% | +50.70% | +152.78% | 1,024B | |
| +0.21% | -2.68% | +53.20% | +50.87% | 618B | |
| -2.51% | -3.25% | +28.54% | +67.99% | 443B | |
| +0.79% | -0.81% | +40.08% | +33.81% | 349B | |
| -0.81% | -1.43% | +33.94% | +42.24% | 297B | |
| -7.48% | -6.71% | +7.97% | +10.31% | 264B | |
| -0.11% | -5.93% | -1.87% | -42.77% | 209B | |
| -0.64% | +2.43% | +29.74% | +67.16% | 208B | |
| -0.82% | +0.70% | +15.05% | +72.05% | 162B | |
| Average | +0.04% | -1.35% | +28.59% | +50.49% | 397.08B | |
| Weighted average by Cap. | +0.34% | -2.17% | +36.90% | +73.27% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 17.02B 178M 155M 144M 132M 250M 254M 1.7B 667M 8.47B 670M 655M 28.41B | 18.12B 190M 165M 154M 141M 266M 270M 1.81B 710M 9.02B 713M 697M 30.24B |
| Net income | 962M 10.07M 8.76M 8.15M 7.48M 14.13M 14.35M 96.07M 37.71M 479M 37.83M 37M 1.61B | 1.18B 12.36M 10.75M 10M 9.18M 17.34M 17.61M 118M 46.28M 588M 46.43M 45.41M 1.97B |
| Net Debt | 121M 1.26M 1.1M 1.02M 938K 1.77M 1.8M 12.04M 4.73M 60.01M 4.74M 4.64M 201M | -928K -9.72K -8.45K -7.87K -7.22K -13.64K -13.85K -92.72K -36.39K -462K -36.51K -35.71K -1.55M |
Employees
1,814
Sector
Pharmaceuticals
Calendar
Aug. 04
Earnings release - Q1 2027
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-03 | ₹57.65 | +1.07% | 5,950,210 |
| 26-07-31 | ₹57.04 | +1.10% | 2,542,492 |
| 26-07-30 | ₹56.42 | -2.47% | 3,524,842 |
| 26-07-29 | ₹57.85 | +4.61% | 6,074,005 |
| 26-07-28 | ₹55.30 | -2.40% | 3,092,284 |
- Stock Market
- Stocks
- MOREPENLAB Stock
- MOREPENLAB Stock
Select your edition
All financial news and data tailored to specific country editions
